With strong fundamental and undervalued price, LINCOLN PHARMA can be new multibagger. FIIs increasing stakes, company consistently outperforming market.
Rounding bottom completed. Breakout expected soon. Levels mentioned in chart.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.